Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Jiangbin Ye"'
Autor:
Bo He, Lauren Stoffel, Clifford Jiajun He, Kumsun Cho, Albert M. Li, Haowen Jiang, Brittany M. Flowers, Kha The Nguyen, Kelly Wen Wang, Audrey Yixin Zhao, Meng-Ning Zhou, Sofia Ferreira, Laura D. Attardi, Jiangbin Ye
Publikováno v:
Cell Death and Disease, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract As a highly heterogeneous tumor, pancreatic ductal adenocarcinoma (PDAC) exhibits non-uniform responses to therapies across subtypes. Overcoming therapeutic resistance stemming from this heterogeneity remains a significant challenge. Here, w
Externí odkaz:
https://doaj.org/article/49624cfd032446e1b3b7c7e99edf32b1
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 12, Pp 891-897 (2023)
Externí odkaz:
https://doaj.org/article/299da660e8eb46b88e26c382bcae3cb8
Autor:
Pingting Liu, Wei Chen, Haowen Jiang, Haoliang Huang, Liping Liu, Fang Fang, Liang Li, Xue Feng, Dong Liu, Roopa Dalal, Yang Sun, Paymaan Jafar-Nejad, Karen Ling, Frank Rigo, Jiangbin Ye, Yang Hu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 32, Iss , Pp 13-27 (2023)
Optic neuropathy is a group of optic nerve (ON) diseases with progressive degeneration of ON and retinal ganglion cells (RGCs). The lack of neuroprotective treatments is a central challenge for this leading cause of irreversible blindness. SARM1 (ste
Externí odkaz:
https://doaj.org/article/21cfe349df9147d1ac310e2cc813cb45
Autor:
Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, Xinjing Xu, Francisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Jiangbin Ye, Thales Papagiannakopoulos, Chao Lu
Publikováno v:
Cell Reports, Vol 43, Iss 1, Pp 113629- (2024)
Summary: The interplay between metabolism and chromatin signaling is implicated in cancer progression. However, whether and how metabolic reprogramming in tumors generates chromatin vulnerabilities remain unclear. Lung adenocarcinoma (LUAD) tumors fr
Externí odkaz:
https://doaj.org/article/84edbc8d07a24ae2ad1662e369769cc7
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The term ‘magic bullet’ is a scientific concept proposed by the German Nobel laureate Paul Ehrlich in 1907, describing a medicine that could specifically and efficiently target a disease without harming the body. Oncologists have been looking for
Externí odkaz:
https://doaj.org/article/185f2d556b834ac4add12e56e9990e04
Autor:
Amy Tarangelo, Leslie Magtanong, Kathryn T. Bieging-Rolett, Yang Li, Jiangbin Ye, Laura D. Attardi, Scott J. Dixon
Publikováno v:
Cell Reports, Vol 22, Iss 3, Pp 569-575 (2018)
How cancer cells respond to nutrient deprivation remains poorly understood. In certain cancer cells, deprivation of cystine induces a non-apoptotic, iron-dependent form of cell death termed ferroptosis. Recent evidence suggests that ferroptosis sensi
Externí odkaz:
https://doaj.org/article/65fa87ec72d24c9a89ee70935269d022
Autor:
Stacey L Lehman, George J Cerniglia, Gregg J Johannes, Jiangbin Ye, Sandra Ryeom, Constantinos Koumenis
Publikováno v:
PLoS Genetics, Vol 11, Iss 6, p e1005212 (2015)
Multiple transcripts encode for the cell cycle inhibitor p21(Cip1). These transcripts produce identical proteins but differ in their 5' untranslated regions (UTRs). Although several stresses that induce p21 have been characterized, the mechanisms reg
Externí odkaz:
https://doaj.org/article/562337064b924c5ab48c02c35c3caf70
Autor:
Li, Albert M., Jiangbin Ye
Publikováno v:
Annual Review of Cancer Biology; 2024, Vol. 8 Issue 1, p35-58, 24p
Autor:
Bo He, Lauren Stoffel, Clifford He, Kumsun Cho, Albert Li, Haowen Jiang, Brittany Flowers, Sofia Ferreira, Meng-Ning Zhou, Laura Attardi, Jiangbin Ye
As a highly heterogeneous tumor, pancreatic ductal adenocarcinoma (PDAC) exhibits non-uniform responses to therapies across subtypes. Overcoming therapeutic resistance due to tumor heterogeneity in PDAC remains a challenge. Here, we report that Vitam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e97b772cc5304db30300c031926a0e
https://doi.org/10.21203/rs.3.rs-2857176/v1
https://doi.org/10.21203/rs.3.rs-2857176/v1
Autor:
Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, Xinjing Xu, Francisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Jiangbin Ye, Thales Papagiannakopoulos, Chao Lu
Publikováno v:
bioRxiv
Interplay between metabolism and chromatin signaling have been implicated in cancer initiation and progression. However, whether and how metabolic reprogramming in tumors generates specific epigenetic vulnerabilities remain unclear. Lung adenocarcino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d657bad4f4caa7301c17510eb829a159
https://doi.org/10.1101/2023.04.24.538118
https://doi.org/10.1101/2023.04.24.538118